PsyBio Therapeutics Corp. (PSYBF)
USD 0.0
(-98.0%)
USD 0.0
(-98.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | -4.55 Million USD | 42.54% |
| 2021 | -8.22 Million USD | -27.85% |
| 2020 | -6.43 Million USD | -16414.45% |
| 2019 | -38.97 Thousand USD | -86.83% |
| 2018 | -20.86 Thousand USD | 47.65% |
| 2017 | -39.84 Thousand USD | 48.27% |
| 2016 | -77.03 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q1 | -801.47 Thousand USD | 15.38% |
| 2023 Q2 | -156.99 Thousand USD | 80.41% |
| 2022 Q2 | -1.38 Million USD | 6.6% |
| 2022 Q4 | -947.15 Thousand USD | -2.67% |
| 2022 FY | -4.72 Million USD | 42.54% |
| 2022 Q1 | -1.47 Million USD | 27.38% |
| 2022 Q3 | -922.48 Thousand USD | 33.18% |
| 2021 FY | -8.22 Million USD | -27.85% |
| 2021 Q1 | -12.53 Thousand USD | -118.04% |
| 2021 Q2 | -12.38 Thousand USD | 1.25% |
| 2021 Q3 | -12.33 Thousand USD | 0.35% |
| 2021 Q4 | -2.03 Million USD | -16394.25% |
| 2020 Q2 | -24.52 Thousand USD | -2375.42% |
| 2020 FY | -6.43 Million USD | -16414.45% |
| 2020 Q4 | 69.52 Thousand CAD | 110.79% |
| 2020 Q3 | -644.25 Thousand USD | -2527.27% |
| 2020 Q1 | -990.62 USD | 90.61% |
| 2019 Q4 | -10.55 Thousand CAD | 0.0% |
| 2019 FY | -38.97 Thousand USD | -86.83% |
| 2018 FY | -20.86 Thousand USD | 47.65% |
| 2017 FY | -39.84 Thousand USD | 48.27% |
| 2016 FY | -77.03 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | -241.068% |
| Arch Therapeutics, Inc. | -5.04 Million USD | 9.709% |
| Evofem Biosciences, Inc. | -17.84 Million USD | 74.479% |
| Nascent Biotech, Inc. | -2.22 Million USD | -104.259% |
| Rebus Holdings, Inc. | -664 Thousand USD | -585.953% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 105.565% |
| Qrons Inc. | -643.67 Thousand USD | -607.61% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -1069.168% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 91.794% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -996.259% |
| Skye Bioscience, Inc. | -13.67 Million USD | 66.685% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 93.655% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 192.673% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -1640.265% |
| SQZ Biotechnologies Company | -75.82 Million USD | 93.993% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -59.787% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -196.522% |
| Mesoblast Limited | -84.14 Million USD | 94.587% |
| Marizyme, Inc. | -34.08 Million USD | 86.638% |
| Genus plc | 6.4 Million USD | 171.168% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 146.751% |
| Pharming Group N.V. | -4.87 Million USD | 6.657% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -129.286% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -389.03% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | 45.452% |
| ContraFect Corporation | -56.88 Million USD | 91.994% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -224.876% |
| IMV Inc. | -38.67 Million USD | 88.222% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -65.576% |
| MultiCell Technologies, Inc. | -722.81 USD | -630041.531% |
| ONE Bio Corp. | 13.68 Million USD | 133.291% |
| Accustem Sciences Inc. | -3.74 Million USD | -21.575% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 92.279% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -483.06 Thousand USD | -842.886% |
| Q BioMed Inc. | -3.44 Million USD | -32.189% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 228.665% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -73.347% |
| Biomind Labs Inc. | -1 Million USD | -351.14% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 91.715% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -56.992% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | 31.487% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -144.304% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -15106.751% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 71.299% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -135.677% |
| GB Sciences, Inc. | -1.42 Million USD | -220.64% |
| Alpha Cognition Inc. | -9.7 Million USD | 53.071% |
| HST Global, Inc. | -140.9 Thousand USD | -3132.434% |
| CSL Limited | 3.7 Billion USD | 100.123% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -304.898% |
| Halberd Corporation | -75.05 Thousand USD | -5968.922% |
| Enzolytics Inc. | -2.14 Million USD | -111.966% |
| Agentix Corp. | -1.37 Million USD | -232.036% |
| Resverlogix Corp. | -12.74 Million USD | 64.274% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -43.76% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -425.04 Million USD | 98.928% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -336.276% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -56.013% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -188.392% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -33.767% |
| AVAX Technologies, Inc. | 6.69 Million USD | 168.053% |
| Zenith Capital Corp. | -8.94 Million USD | 49.069% |
| Genscript Biotech Corporation | -415.79 Million USD | 98.905% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -26045.032% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -85.505% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -2555.669% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -127.196% |
| Kadimastem Ltd | -3.04 Million USD | -49.814% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -362.854% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -262.637% |
| BioStem Technologies, Inc. | -7.77 Million USD | 41.448% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -2409.698% |
| LadRx Corporation | -3.82 Million USD | -19.121% |
| Cell Source, Inc. | -4.32 Million USD | -5.303% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -563.036% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -563.036% |
| NovAccess Global Inc. | -2.46 Million USD | -84.644% |
| Affymax, Inc. | -15.04 Million USD | 69.728% |
| Itoco Inc. | -919.14 Thousand USD | -395.542% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -7.463% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -307.035% |
| Mobile Lads Corp. | -554.55 Thousand USD | -721.337% |
| CytoDyn Inc. | -18.05 Million USD | 74.777% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -17995.852% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -1969.596% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -706.542% |
| SYBLEU INC | -149.18 Thousand USD | -2953.175% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -150.767% |
| International Stem Cell Corporation | -663 Thousand USD | -586.987% |
| Bioxytran, Inc. | -3.82 Million USD | -19.229% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -8552.595% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -22292.95% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 87.441% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -181.503% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -518.987% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -46.407% |
| Neutra Corp. | -229.48 Thousand USD | -1884.751% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 74.031% |
| PureTech Health plc | -146.19 Million USD | 96.885% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 78.806% |
| IXICO plc | -1.43 Million USD | -216.961% |
| IntelGenx Technologies Corp. | -9.49 Million USD | 52.01% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 96.261% |
| CSL Limited | 3.81 Billion USD | 100.119% |
| Cellectis S.A. | -108.85 Million USD | 95.816% |